BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2439595)

  • 1. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
    Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
    J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
    Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
    Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    Aparicio P; Vega MA; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
    Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
    Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
    López D; Rojo S; Calvo V; López de Castro JA
    J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
    Rojo S; López D; Calvo V; López de Castro JA
    J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens.
    Spits H; Yssel H; Voordouw A; de Vries JE
    J Immunol; 1985 Apr; 134(4):2294-8. PubMed ID: 2579137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
    Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
    J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
    López D; García-Hoyo R; López de Castro JA
    J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.